Results 41 to 50 of about 755,873 (344)

Emerging immunopharmacological targets in multiple sclerosis. [PDF]

open access: yes, 2015
Inflammatory demyelination of the central nervous system (CNS) is the hallmark of multiple sclerosis (MS), a chronic debilitating disease that affects more than 2.5 million individuals worldwide. It has been widely accepted, although not proven, that the
Abdolmohamad Rostami   +182 more
core   +2 more sources

Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals

open access: yesImmunity & Ageing, 2023
Background Frailty is an intermediate and reversible geriatric syndrome that often precedes dependence. Therefore, its identification is essential to prevent dependence. Several molecules have been proposed as biomarkers of frailty, but none of them have
Leire Iparraguirre   +6 more
doaj   +1 more source

Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis

open access: yesFrontiers in Immunology, 2021
Pregnancy affects the disease course in multiple sclerosis (MS), particularly in the third trimester, where the relapse rate is reduced by as much as two thirds.
Helle Bach Søndergaard   +6 more
doaj   +1 more source

The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases

open access: yesLife, 2023
Multiple sclerosis (MS), neuromyelitis optica (NMO) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) are inflammatory diseases of the central nervous system (CNS) with a multifactorial aetiology.
Jessica Frau   +4 more
doaj   +1 more source

Eye Tracking Impact on Quality-of-Life of ALS Patients [PDF]

open access: yes, 2008
Chronic neurological disorders in their advanced phase are characterized by a progressive loss of mobility (use of upper and lower limbs), speech and social life.
And Vignola, A.   +7 more
core   +1 more source

Noise in multiple sclerosis: unwanted and necessary [PDF]

open access: yes, 2014
As our knowledge about the etiology of multiple sclerosis (MS) increases, deterministic paradigms appear insufficient to describe the pathogenesis of the disease, and the impression is that stochastic phenomena (i.e.
BORDI, Isabella   +7 more
core   +1 more source

MULTIPLE SCLEROSIS [PDF]

open access: yesThe Journal OF Nervous and Mental Disease, 1920
n ...
openaire   +1 more source

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. [PDF]

open access: yes, 2019
We analyzed genetic data of 47,429 multiple sclerosis (MS) and 68,374 control subjects and established a reference map of the genetic architecture of MS that includes 200 autosomal susceptibility variants outside the major histocompatibility complex (MHC)
International Multiple Sclerosis Genetics Consortium
core   +1 more source

Decrypting cancer's spatial code: from single cells to tissue niches

open access: yesMolecular Oncology, EarlyView.
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik   +4 more
wiley   +1 more source

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis [PDF]

open access: yes, 2003
OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness.
Abrams, K.   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy